Drug lookup
Drug reference

Teniposide

Topoisomerase Inhibitor · Antineoplastic

Topoisomerase InhibitorAntineoplasticATC null
CDSCO approvedSchedule H
EXCRETION
not curated
INTERACTIONS
12 major
SEVERE in our sources
PREGNANCY
X
FDA category + note
Top interactionssee all 12
  • AdalimumabSevereDatabaseDDInter
  • BaricitinibSevereDatabaseDDInter
  • CertolizumabSevereDatabaseDDInter
  • CladribineSevereDatabaseDDInter

Mechanism

Teniposide is an epipodophyllotoxin that inhibits DNA synthesis. It acts by damaging DNA, with its toxicity being greatest during the S-phase of the cell cycle.

Indications

Acute lymphoblastic leukemia in childrenRefractory acute lymphoblastic leukemia (ALL) in childrenAcute leukemia in childrenMonocytic leukemia in infantsGlioblastomaNeuroblastomaBrain metastases from small cell carcinomas of the lung

Dosing

Adult
Dosage need not be reduced for patients with impaired renal function.

Pharmacokinetics

Half-life
Multiphasic pattern of clearance: 4 h (after distribution), and another of 10 to 40 h.
Metabolism
Metabolized by CYP3A4/3A5/3A7 enzymes. Transport is influenced by P-glycoprotein (ABCB1).
Excretion
Approximately 45% of the drug is excreted in the urine; as much as 80% is recovered as metabolites.

Side effects

Common
MyelosuppressionNauseaVomiting

Pregnancy & lactation

Pregnancy

X

Drug interactions

Adalimumab
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Baricitinib
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Certolizumab
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Cladribine
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Clozapine
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Deferiprone
Severe
Database

Clinical effect not specified

Source: DDInter

Etanercept
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Fingolimod
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Golimumab
Severe
Database

Clinical effect not specified

Source: DDInter

Infliximab
Severe
Database

Clinical effect not specified

Source: DDInter

Leflunomide
Severe
Database

Clinical effect not specified

Source: DDInter

Measles Virus Vaccine Live Attenuated
Severe
Database

Clinical effect not specified

Source: DDInter

Related guidelines

Other Topoisomerase Inhibitor drugs

Ask House about Teniposide

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: Goodman & Gilman 14e, Katzung·Verified: 2026-05-10 · House clinical team